Published 16:07 IST, January 31st 2024
Sun Pharma Q3 profit up 16% at Rs 2,523 crore
The Mumbai-headquartered drugmaker announced an interim dividend of Rs 8.5 per share
Sun Pharmaceutical Industries, the country’s leading drugmaker, reported better-than estimated second-quarter earnings on Wednesday. | Image:
Unsplash
- Listen to this article
- 2 min read
Advertisement
15:36 IST, January 31st 2024